澳股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

IMRICOR MEDICAL SYSTEMS-CDI

1.845

-0.005-0.27%

成交量：75.80萬

成交額：140.03萬

市值：6.62億

市盈率：-10.73

高：1.930

開：1.900

低：1.825

收：1.850

52周最高：2.250

52周最低：1.275

股本：3.59億

流通股本：2.75億

量比：0.73

換手率：0.28%

股息：- -

股息率：- -

每股收益(TTM):-0.172

每股收益(LYR):-0.115

淨資產收益率：-143.12%

總資產收益率：-26.53%

市淨率：16.22

市盈率(LYR):-16.03

資料載入中...

總覽公司新聞資訊公告

概念

科技股+0.05%

醫藥生物股+1.18%

資金流向

資金流入：

資金流出：

新聞資訊

Imricor Medical Systems預期獲FDA批准，新增資本設備將拓寬美國市場產品線

Imricor Medical Systems 提交Navtrac與Navtrac-mr可控導引器尋求美國FDA 510(k)許可

Imricor Medical Systems股價上漲，因兩款設備獲得美國FDA批准

Imricor Medical Systems獲FDA 510(k)許可擴大Vision-Mr診斷導管兒科適應症標籤

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"老虎國際,美股交易,港股交易,交易美股,股票信息,股價,美股行情,美股打新,港股打新,IPO打新,購買美股,全球投資","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/hant/stock/IMR.AU"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"IMR.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"IMR.AU\",,,,,undefined,":{"symbol":"IMR.AU","market":"AU","secType":"STK","nameCN":"IMRICOR MEDICAL SYSTEMS-CDI","latestPrice":1.845,"timestamp":1789452720000,"preClose":1.85,"halted":0,"volume":757999,"delay":0,"changeRate":-0.002702702702702765,"nameEN":"IMRICOR MEDICAL SYSTEMS-CDI","floatShares":275046474,"shares":358542497,"eps":-0.17189863683437973,"marketStatus":"未開盤","change":-0.005,"latestTime":"09-15 16:12:00 AEST","open":1.9,"high":1.93,"low":1.825,"amount":1400333,"amplitude":0.056757,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.17189863683437973,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":0,"beginTime":1789516800000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":1.85,"openAndCloseTimeList":[[1789430400000,1789452000000]],"volumeRatio":0.7336332782275758,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"IMR.AU","preClose":1.845,"auctionPrice":1.84,"auctionVolume":1000,"auctionTime":1789515971842,"referenceTime":1789468203091,"auction":1,"marketStatus":"盘前竞价","timestamp":1789515971842}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"IMR.AU\",,,,,undefined,":{"symbol":"IMR.AU","floatShares":275046474,"roa":"-26.53%","roe":"-143.12%","lyrEps":-0.115075,"volumeRatio":0.7336332782275758,"shares":358542497,"dividePrice":0,"high":1.93,"amplitude":0.056757,"preClose":1.85,"low":1.825,"week52Low":1.275,"pbRate":"16.22","psRate":"3925.79","week52High":2.25,"institutionHeld":0,"latestPrice":1.845,"eps":-0.17189863683437973,"divideRate":0,"volume":757999,"delay":0,"ttmEps":-0.17189863683437973,"open":1.9,"prevYearClose":1.53,"prevWeekClose":1.82,"prevMonthClose":1.945,"prevQuarterClose":1.845,"fiveDayClose":1.895,"twentyDayClose":2.07,"sixtyDayClose":1.83,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IMR.AU\",params:#limit:5,,,undefined,":[{"date":"2026-08-10","symbol":"IMR.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1786320000000,"name":null,"time":"","dateTimestamp":1786284000000,"actualEps":null},{"date":"2026-02-24","symbol":"IMR.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1771887600000,"name":null,"time":"","dateTimestamp":1771851600000,"actualEps":null},{"date":"2025-08-26","symbol":"IMR.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756166400000,"name":null,"time":"","dateTimestamp":1756130400000,"actualEps":null},{"date":"2025-02-26","symbol":"IMR.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1740524400000,"name":null,"time":"","dateTimestamp":1740488400000,"actualEps":null},{"date":"2024-08-28","symbol":"IMR.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724803200000,"name":null,"time":"","dateTimestamp":1724767200000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IMR.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IMR.AU\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1170228291","title":"Imricor Medical Systems預期獲FDA批准，新增資本設備將拓寬美國市場產品線","url":"https://stock-news.laohu8.com/highlight/detail?id=1170228291","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1170228291?lang=zh_tw&edition=fundamental","pubTime":"2026-08-10 06:40","pubTimestamp":1786315209,"startTime":"0","endTime":"0","summary":"Imricor Medical Systems（IMRICOR MEDICAL SYSTEMS-CDI）预计将获得美国食品药品监督管理局（FDA）对更多资本设备的审批许可。此举有望显著扩展该公司向美国客户提供的产品组合，进一步丰富其市场供给。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7503","IMR.AU","BK7007","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1133376223","title":"Imricor Medical Systems 提交Navtrac與Navtrac-mr可控導引器尋求美國FDA 510(k)許可","url":"https://stock-news.laohu8.com/highlight/detail?id=1133376223","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1133376223?lang=zh_tw&edition=fundamental","pubTime":"2026-07-20 07:26","pubTimestamp":1784503570,"startTime":"0","endTime":"0","summary":"Imricor Medical Systems 已正式向美国食品药品监督管理局提交了其Navtrac与Navtrac-mr可控导引器，以寻求510(k)市场准入许可。这一步骤标志着该公司在推进其创新医疗设备商业化进程中的关键进展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","BK7007","BK7503","IMR.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648520080","title":"Imricor Medical Systems股價上漲，因兩款設備獲得美國FDA批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2648520080","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648520080?lang=zh_tw&edition=fundamental","pubTime":"2026-07-02 09:14","pubTimestamp":1782954879,"startTime":"0","endTime":"0","summary":"BUZZ-Imricor Medical Systems股价上涨，因两款设备获得美国FDA批准7月2日-** 在澳大利亚证券交易所（ASX）上市的Imricor Medical Systems公司（IMR.AX）股价一度上涨16.3%，至2.1澳元，创下自4月下旬以来的最高水平** 这家总部位于美国的医疗设备制造商 (link) 的NorthStar定位系统和Vision-MR诊断导管获得美国食品药品监督管理局（FDA）批准，将适应症范围扩展至儿科患者** 此次批准将使该公司能够将这两款产品推广至所有年龄段的患者，包括儿童和青年** 该股今年以来累计涨幅已超过30%","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260702:nL4T43402U:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7007","IMR.AU","BK7508","BK7503"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1124120626","title":"Imricor Medical Systems獲FDA 510(k)許可 擴大Vision-Mr診斷導管兒科適應症標籤","url":"https://stock-news.laohu8.com/highlight/detail?id=1124120626","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1124120626?lang=zh_tw&edition=fundamental","pubTime":"2026-07-02 06:37","pubTimestamp":1782945436,"startTime":"0","endTime":"0","summary":"Imricor Medical Systems宣布，其Vision-Mr诊断导管已获得美国食品药品监督管理局（FDA）的510(k)许可，用于扩大儿科适应症的标签范围。这一监管批准标志着该产品在儿科心脏介入磁共振成像领域应用的重要拓展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7007","BK7508","BK7503","IMR.AU"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":2,"pageCount":1,"totalSize":6,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/IMR.AU\",params:#limit:6,delay:true,,,undefined,":[{"market":"AU","name":"科技股","id":"package_au_concept_kjg","bkCode":"BK7503","changeRate":0.000466},{"market":"AU","name":"醫藥生物股","id":"package_au_concept_yyswg","bkCode":"BK7508","changeRate":0.011805}]}}